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Abstract
We have identified and functionally characterized the Xenopus Xlmo4 gene, which encodes a member of the LIM-domain-only protein
family. Xlmo4 is activated at gastrula stages in the mesodermal marginal zone probably in response to BMP4 signaling. Soon after, Xlmo4
is downregulated in the dorsal region of the mesoderm. This repression seems to be mediated by organizer-expressed repressors, such as
Gsc. Xlmo4 downregulation is necessary for the proper formation of this territory. Increasing Xlmo4 function in this region downregulates
Spemman Organizer genes and suppresses dorsal-anterior structures. By binding to Ldb1, Xlmo4 may restrict the availability of this cofactor
for transcription factors expressed at the Spemman Organizer. In the ventral mesoderm, Xlmo4 is required to establish the identity of this
territory by acting as a positive cofactor of GATA factors. In the neural ectoderm, Xlmo4 expression depends on Xiro homeoprotein activity.
In this region, Xlmo4 suppresses differentiation of primary neurons and interferes with gene expression at the Isthmic Organizer, most likely
by displacing Ldb1 from active transcription factor complexes required for these processes. Together, our data suggest that Xlmo4 uses
distinct mechanisms to participate in different processes during development.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The LIM domain is a cysteine-rich zinc-binding motif
present in transcriptional regulators important for develop-
ment of invertebrates and vertebrates. This domain was
originally discovered in proteins containing homeodomains,
the so-called LIM homeoproteins (Lhx) (reviewed in Bach,
2000; Dawid et al., 1998; Hobert and Westphal, 2000).
During vertebrate development LIM homeoproteins are re-
quired for processes such as the correct movement of dorsal
mesoderm (Spemann Organizer) cells (Hukriede et al.,
2003), maintenance of dorsal mesoderm identity (Kodjaba-
chian et al., 2001; Mochizuki et al., 2000; Shawlot and
Behringer, 1995), and the correct specification and differ-
entiation of a subtype of neurons (Pfaff et al., 1996; Sharma
et al., 1998; Tanabe et al., 1998; Thaler et al., 2002; Thor et
al., 1999).
LIM homeoproteins interact with the LIM-domain-bind-
ing proteins Ldb1/NL1/Clim2 and Ldb2/Clim1 (reviewed in
Bach, 2000; Dawid et al., 1998; Hobert and Westphal,
2000). Ldb1 contains a dimerization domain and a LIM-
interacting region and, in many developmental processes,
Ldb1 and Lhx appear to form an active tetramer that con-
tains two molecules of each of these proteins (Mila´n and
Cohen, 1999; Rinco´n-Limas et al., 2000; Thaler et al., 2002;
van Meyel et al., 1999). In addition, Ldb1 also form mul-
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tiprotein complexes with transcription factors of the bHLH,
GATA, and Otx families (reviewed in Bach, 2000; Dawid et
al., 1998; Hobert and Westphal, 2000). Mutation of Ldb1 in
mice (Mukhopadhyay et al., 2003) or interference with
Ldb1 function in zebrafish (Becker et al., 2002) cause mul-
tiple developmental defects, such as anterior truncations,
partial axis duplication, and alteration of neuronal differen-
tiation.
The functional tetramer of Lhx and Ldb1 proteins was
initially described for the Drosophila LIM homeoprotein
Apterous (Ap) and the Ldb1 homologue Chip (Mila´n and
Cohen, 1999; Rinco´n-Limas et al., 2000; van Meyel et al.,
1999), where it was found to be necessary for defining the
dorsal compartment of the imaginal wing discs. The Ap-
Chip interaction takes place through the LIM domains of
Ap. Moreover, this interaction is regulated by Beadex/
dLmo, a member of the Lmo (LIM domain only) family of
proteins that are composed almost exclusively of two LIM
domains. Beadex, through its LIM domains, binds to and
sequesters Chip, thus antagonizing Ap function (Mila´n and
Cohen, 1999; Mila´n et al., 1998; Shoresh et al., 1998; van
Meyel et al., 1999; Weihe et al., 2001; Zeng et al., 1998).
In vertebrates, four Lmo proteins (Lmo1–4) have been
identified (Foroni et al., 1992; Grutz et al., 1998; Kenny et
al., 1998; Lane et al., 2002; Larson et al., 1995, 1996;
Sugihara et al., 1998). In addition to their interaction with
Ldb1, vertebrate Lmos also act as positive cofactors of other
transcription factors. For instance, during blood develop-
ment, Lmo2 forms a multiprotein complex with Ldb1,
GATA1, and the bHLH factors SCL and E12/E47 (Osada et
al., 1995; Vitelli et al., 2000; Wadman et al., 1997). Tar-
geted gene disruption in mice (Yamada et al., 1998) and
functional studies in Xenopus (Mead et al., 2001) have
demonstrated an essential function of Lmo2 in blood for-
mation. In Xenopus, Xlmo3 interacts with and increases the
transcriptional activity of the neural-specific bHLH protein
XHEN-1 during primary neurogenesis (Bao et al., 2000). In
addition, mouse Lmo4 can interact with the homologue of
the Drosophila Deformed epidermal autoregulatory factor 1
(Sugihara et al., 1998).
In this work, we describe the identification and func-
tional analysis of the Xenopus lmo4 (Xlmo4) gene. Xlmo4
was isolated in a screen designed to identify genes regulated
by the Xiro homeoproteins, an evolutionary conserved
group of transcription factors encoded by the iroquois (Iro/
Irx) genes. The Iro/Irx genes have multiple functions during
vertebrate and invertebrate development (reviewed in
Cavodeassi et al., 2001), among them the anterior-posterior
and the dorsal-ventral subdivision of the neural vertebrate
territory (reviewed in Go´mez-Skarmeta and Modolell,
2002). Here we show that Xlmo4 acts, by means of different
mechanisms, on several processes during development.
Thus, during gastrulation, Xlmo4 is required for acquisition
of ventral mesoderm identity, in association with GATA
transcription factors, and for the restriction of Ldb1 avail-
ability for some Spemman Organizer transcription factors.
At neurula stages, Xlmo4 is necessary to delimit primary
neuron differentiation and to modulate gene expression at
the Isthmus Organizer of the midbrain-hindbrain boundary.
Materials and methods
Isolation of Xlmo4
Twenty animal caps from control or injected (1 ng of
Xirol mRNA) embryos were excised at stage 10 and cul-
tured until stage 18. Total RNA was extracted and cDNA
was synthesized using the SMART PCR cDNA Synthesis
Kit (Clontech). The resulting two populations of cDNAs
were used to prepare a subtraction library using the Clon-
tech PCR-Select cDNA Subtraction Kit. The library was
ligated to the pGEM-T Easy vector (Promega) and trans-
formed into E. coli. One of the clones contained a 596-bp
cDNA fragment with a full-length ORF that encodes
Xlmo4.
Plasmid constructions
The primers 5-GACGAATTCAATGGTGAATAAC-
CGGAG-3 and 5-CTTCTCGAGCATCTGGCTCA-
CAGCTC-3 were used to amplify the Xlmo4 coding re-
gion. The PCR fragment was subcloned in pGEM-T easy,
sequenced, excised with EcoRI and XhoI (in bold in
the primer sequences), and cloned in pCS2-MT plasmid
(Turner and Weintraub, 1994) to obtain the MT-Xlmo4
construct. To prepare the Xlmo4-MT plasmid, the Xlmo4
gene was amplified with the primers 5-GAGGATC-
GAACGAGGATCAGTAATGG-3 and 5-CGATC-
GATCTTTCTGGTCAGGGAGC-3. The PCR fragment
was subcloned in PGEM-T easy, sequenced, excised with
BamHI and ClaI (in bold in the primer sequences), and
cloned in pCS2-MT plasmid. The pCS2-Xlmo4 construct
was obtained by removing the carboxy-terminal region that
contain the MT domain from pCS2-Xlmo4-MT with SacI
(which digest within the Xlmo4 coding region) and XbaI and
replacing this fragment by an equivalent SacI-XbaI frag-
ment obtained from pCS2-MT-Xlmo4. To prepare the hor-
mone inducible construct, we PCR-amplified the Xlmo4
coding region using the primers 5-GACGAATTCAATG-
GTGAATAACCGGAG-3 and 5-CGCTCGAGGAGGG-
GATTCAAGTGG-3. This fragment was subcloned in
pGEM-T easy, sequenced, excised with EcoRI and XhoI,
and cloned in PCS2-MT plasmid. The hormone inducible
domain was obtained by PCR using the oligonucleotides
5-GAGATCCCCTCTAGAGGGACC-3 and 5-CAT-
CAAAAGTGGCTCGAGCCCGCCGCT-3 from a
MyoD-GR plasmid kindly donated by H. Sive. The ampli-
fied fragment was cut with XbaI and XhoI, subcloned in
pBluescript, and sequenced. The Xlmo4 region was excised
from pCS2-MT plasmid with EcoRI and XbaI, and the
inducible domain digested with XbaI and XhoI. These two
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fragments were ligated to the pCS2-MT plasmid digested
with EcoRI and XhoI generating the pCS2-MT-Xlmo4-GR
construct. The pCMX-Engrailed-Lmo4 vector was gener-
ated by isolating a fragment representing full-length mouse
Lmo4 from pGBT9Lmo4 (Sugihara et al., 1998) by cutting
with BamHI and partially cutting with EcoRI, thus allowing
in frame fusion between the N-terminally located Engrailed
repression domain and Lmo4. The GATA2 constructs were
generated by PCR, using the pSP64T-GATA2a plasmid
(Zon et al., 1991) as a template and the following oligonu-
cleotides: 5-AGCTCATATGGAAGTCGCCACTGACCAG-
CCCCGT-3 and 5-AGCTGGATCCCCATAGCCGTCAC-
CATGCTGGAGTGG-3 (GATA2 full length); 5-AGCT-
CATATGGAAGTCGCCACTGACCAGCCCCGT-3 and
5-AGCTGGATCCACACTCTCTCCCTTCTGAGCAGGA-3
(GATA2 aa:1–266); and 5-AGCTCATATGAAGAGCA-
GATCCTGCTCAGAAGGGAG-3 and 5-AGCTGGATC-
CCCATAGCCGTCACCATGCTGGAGTGG-3 (GATA2 aa:
257–452). The PCR products were cut with NdeI and BamHI,
and cloned into the yeast two-hybrid vector pGADT7 (Clon-
tech). The GATA2 fragments were also cloned into the eu-
karyotic expression vector pCDNA3 with the in-frame HA
tags.
DNA sequencing
DNA sequencing was performed with ABI chemistry in
an automatic DNA sequencer. Custom synthesized oligonu-
cleotides were from ISOGEN (Bioscience BV, Maarsesen,
The Netherlands).
Whole-mount in situ hybridization, X-Gal, and antibody
staining
Antisense RNA probes were prepared from cDNAs us-
ing digoxigenin or fluorescein (Roche) as labels. Specimens
were prepared, hybridized, and stained as described (Har-
land, 1991). Double in situ hybridizations were performed
as described (Go´mez-Skarmeta et al., 1998). X-Gal staining
was carried out according to Coffman et al. (1993). Anti-
body staining was performed (Turner and Weintraub, 1994)
after in situ hybridization and bleaching of the embryos
using mouse monoclonal anti-Myc from BabCo.
In vitro RNA synthesis
All DNAs were linearized and transcribed as described
(Harland and Weintraub, 1985) with GTP cap analogue
(New England Biolabs). After DNAse treatment, RNA was
extracted with phenol-chloroform, column purified, and pre-
cipitated with ethanol. mRNAs for injection were resus-
pended in water.
RT-PCR analysis
Embryos were injected with the corresponding mRNA in
the animal region at one-cell stage, caps were explanted at
stage 9, and aged until stage 19–20 when RNA was ex-
tracted. The RNA was treated with DNAse and processed
for RT-PCR as described (Gawantka et al., 1995).
Protein-protein interaction by GST pulldown and
coimmunoprecipitations
The GST pulldown assays were performed as previously
described (Sugihara et al., 2001). Briefly, GST protein or
GST-Lmo4 fusion protein were incubated with 35S-labeled
in vitro translated GATA proteins under previously de-
scribed conditions except that incubation was carried out at
room temperature for 30 min. After washing three times, the
glutathione-agarose beads were resuspended in SDS sample
buffer, boiled, and analyzed on 10% SDS-polyacrylamide
gels. Coimmunoprecipitations, using 35S-labeled in vitro
translated proteins, were performed as previously described
(Sugihara et al., 1998), using Myc and HA antibodies rec-
ognizing the tagged proteins. Coimmunoprecipitations in
extracts from HEK293T cells were performed as previously
described, using Myc antibody recognizing tagged Lmo4
and HA antibody recognizing tagged Gata2 constructs
(Sugihara et al., 2001).
Fig. 1. Protein encoded by Xlmo4 and expression pattern of this gene during Xenopus development. (A) Amino acid sequence alignment of Xenopus, human,
and chick Lmo4 proteins (accession numbers AJ511277, U24576, and AF532926, respectively). Identical residues are indicated by dashes. Asterisks
correspond to gaps inserted to maximize alignment. (B) Xlmo4 mRNA expression (upper panel) at different developmental stages examined by RT-PCR and
compared with the control Histone H4 mRNA (lower panel). 1–2c, one–two-cell stage; s6–14, stages 6–14. Vegetal views (C and D), dorsal views (E, and
J–M), sagital views (F–1), and lateral views (J inset, N, and O) of embryos showing the expression of Xlmo4 (C–F and I–O), Xlim1 (G), or Otx2 (H). (C)
At early gastrula stage (stg), Xlmo4 is expressed in the mesodermal region. (D) At mid gastrula, Xlmo4 expression in the dorsal mesoderm starts to decline
(arrowhead). (E) At the end of gastrulation and beginning of neurulation, Xlmo4 mRNA is not longer detected in the dorsal mesoderm (arrow) and
accumulates in two symmetrical patches of the neural ectoderm (arrowhead). (F–H) Sagittal sections through a stage 10 embryo (as shown in C by the red
line) indicate that Xlmo4 is expressed in the dorsal mesendodermal cells (F, black arrowhead) that also express Xlim1 and Otx2 (G and H, respectively;
arrowheads). At this stage, Xlmo4 mRNA is also present in the ventral mesodermal cells (F, red arrowhead). Arrows point at the blastopore: (I) Sagittal
sections through a stage 12 embryo (as shown in E by the red line) indicate that Xlmo4 is expressed in the neuroectoderm, anterior endomesodermal cells
(red arrow), and ventral mesoderm (red arrowhead), but not in the notochord (black arrowhead). (J–L) The Xlmo4 neural expression domains persist during
all neurula stages. From late gastrula onward, Xlmo4 expression is also detected in the ventral epidermis (inset in J; N, and O, arrowheads). A double staining
of Xlmo4 (purple) and Otx2 (cyan) indicate that the anterior limit of the domain of Xlmo4 expression is within the caudal Otx2 territory (K). (M) At late
neurula stage, Xlmo4 mRNA becomes detectable in an anterior band within the forebrain (arrowhead), and in the cephalic neural crests (arrow). (N and O)
At later stages, Xlmo4 transcripts are also present in migrating neural crest cells (arrows), in the brain, and in the ventral epidermis (arrowhead).
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Embryos, explants, microinjection of mRNA and MO
oligonucleotides, and hormone treatment
Xenopus embryos were obtained and animal caps were
prepared as described (Go´mez-Skarmeta et al., 1998) and
staged according to Niewkoop and Faber (1967). Synthetic
mRNAs were injected into embryos at the one- or two-cell
stage using 8–12 nl. 10–50 ng of an Xlmo4 antisense
morpholino (MO) oligonucleotide (5-ACTCGGAGATC-
CGGTTATTCACCAT-3) was injected into embryos at the
one- or two-cell stage using 8–12 nl. To activate the hor-
mone-inducible Xlmo4 quimeric protein, injected embryos
were incubated at different stages with dexamethasone (10
g/ml).
Results
Isolation and expression of Xlmo4
A Xenopus subtraction library enriched in cDNA frag-
ments of genes putatively activated by Xiro1 overexpression
was prepared by subtracting the population of cDNAs from
animal caps injected with Xiro1 mRNA from those obtained
from uninjected caps (see the materials and methods sec-
tion). One cDNA (596 bp) from this enriched library en-
coded a Xenopus homologue of the LIM-domain-only pro-
tein Lmo4 (Fig. 1A). Its sequence was 83% identical (90%
considering conservative substitutions) to that of human and
chick Lmo4 proteins. Hence, the corresponding gene was
named Xlmo4.
We first performed RT-PCR analyses to determine the
presence of Xlmo4 mRNA at different developmental
stages. During early development, Xlmo4 mRNA was
present at similar levels from the one-cell to the neurula
stage, with only a slight reduction of Xlmo4 mRNA accu-
mulation during the midblastula transition (Fig. 1B). This
indicates the presence of both maternal and zygotic Xlmo4
mRNA. We then examined the spatial distribution of Xlmo4
mRNA by whole-mount in situ hybridization. At the begin-
ning of gastrulation (stage 10), Xlmo4 mRNA is found
throughout most of the marginal zone (Fig. 1C). Slightly
later (stage 11), Xlmo4 expression is downregulated in the
dorsal most region (Fig. 1D, arrowhead) and finally disap-
pears from this territory (Fig. 1E, arrow). By this stage,
Xlmo4 expression extends toward neuroectodermal cells
(Fig. 1E, arrowhead). Section analyses of gastrulating em-
bryos indicate that at the beginning of gastrulation Xlmo4
mRNA is present, although at low levels, in dorsal mesen-
dodermal cells that also express both Xlim1 and Otx2 (Fig.
1F–H, black arrowheads) and, at higher levels, in ventral
mesodermal cells (Fig. 1F, red arrowheads). Section analy-
ses of late gastrula embryos (Fig. 1I) show that Xlmo4 is
found in the neuroectoderm, anterior endodermal cells (red
arrow) and ventral mesodermal cells (red arrowhead), but
not in dorsal mesodermal cells (black arrowhead). During
Fig. 2. Regulation of Xlmo4 expression. Dorsal views (A–F) of midneurula and
vegetal views of gastrula (G and H) in control and injected embryos. Injection side
was determined by X-Gal staining (B) or by anti-myc staining (C–F). (A)
Embryo doubly hybridized for Xiro1 (cyan) and Xlmo4 (purple). Note that
Xlmo4 expression in the neural plate is coincident within the Xiro bilateral
bands. Inset shows a single hybridization for Xiro1. (B and C) Embryos
injected with 100 or 500 pg of MT-Xiro3 or MT-Xiro1 mRNAs respectively.
In the injected side (arrowheads), the domain of Xlmo4 expression is ex-
panded. (D) Similar ectopic expression of Xlmo4 is detected in embryos
injected with 500 pg of HD-EnR mRNA (arrowhead). (E and F) In embryos
injected with 500 pg of HD-GR (E) or HD-GR-E1A (F) mRNAs, Xlmo4 is
downregulated (arrowheads) when Dex was added at stage 12. These effects are
not observed in the absence of Dex (insets). (G) Embryo injected with dnBMP4R
mRNA (125 pg). Xlmo4 expression is reduced (arrowhead). (H) Ectopic
ventral expression of gsc mRNA (150 pg) downregulates Xlmo4 (arrowhead).
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neurulation, neuroectodermal cells expressing Xlmo4 be-
come localized in bilateral patches of the neural plate (Fig.
1J–L). In addition, from late gastrula onwards, Xlmo4
mRNA is also detected in the ventral epidermis (Fig. 1J,
arrowhead in inset). Double staining indicates that the an-
terior limit of the Xlmo4 domain partially overlap with the
caudal part of the Otx2 domain (Fig. 1K, arrowhead). At late
neurula stages, Xlmo4 mRNA is also found in a more rostral
territory (Fig. 1M, arrowhead) and in the anterior neural
crests (Fig. 1M, arrow). At later stages, Xlmo4 transcripts
are found in the brain, in the migrating neural crests (Fig.
1N and O, arrows), and in the ventral epidermis (Fig. 1N
and O, arrowheads). The expression pattern of Xlmo4 in the
neuroectoderm is largely similar to that of the zebrafish
Lmo4 gene. However, in contrast to Xlmo4, zebrafish Lmo4
is not expressed in the marginal zone of gastrulating em-
bryos. In addition, zebrafish Lmo4, but not Xlmo4, is de-
tected in the developing somites (Lane et al., 2002).
Xlmo4 expression in the neural plate requires Xiro
activity, while that in the mesoderm depends on BMP-4
signaling
Since we found Xlmo4 in a subtraction library enriched
in genes putatively activated by Xiro overexpression, we
examined whether Xlmo4 expression requires the activity of
Xiro. In contrast to Xiro1 (Go´mez-Skarmeta et al., 1998),
Xlmo4 is not expressed in the prospective neural plate of the
early gastrula. However, Xlmo4 is expressed in this territory
of the neurula embryo and its expression domain coincides
with the bilateral stripes of Xiro1 (Fig. 2A). Moreover, the
expression of both genes has the same anterior limit. This
temporal and spatial coincidence is consistent with Xiro
regulating Xlmo4. Indeed, injection of either Xiro1, 2, or 3
mRNA expands the territory of expression of Xlmo4 (50–
73%, n  32–30; Fig. 2B and C, arrowheads, and not
shown). It is known that Xiro1 acts as a repressor whose
function can be mimicked or antagonized by constructs
containing the Xiro1 homeodomain fused to the Engrailed
repressor (HD-En) or to the E1A activator (HD-E1A) do-
mains, respectively (Go´mez-Skarmeta et al., 2001). Consis-
tently, we find that injection of HD-En mRNA activates
Xlmo4 ectopically (60%, n  28; Fig. 2D, arrowhead). In
contrast, interference with Xiro1 function accomplished by
expressing either one of two inducible dominant negative
constructs (HD-GR and HD-GR-E1A) downregulated
Xlmo4 in the presence (56–57%, n  28–32; Fig. 2E and F,
arrowheads), but not in the absence (Fig. 2E and F, insets),
of the hormone dexamethasone (Dex). These results indi-
cate that Xiro1 is required for the expression of Xlmo4 in the
neural plate.
We also examined the regulation of Xlmo4 in the meso-
derm. Expression of many genes in the ventral mesoderm
depends on BMP-4 signaling. This was also the case for
Xlmo4. Interference with BMP-4 signaling, accomplished
by expressing a dominant negative BMP-4 receptor (dn-
BMPR4 RNA, 250 pg), significantly reduced Xlmo4 expres-
sion (78%, n  55; Fig. 2G). We have seen that during
gastrulation Xlmo4 was progressively downregulated at the
dorsal mesoderm (Fig. 1D and E). Thus, we examined
whether misexpression of a dorsal mesoderm gene that
encodes a repressor, goosecoid (gsc), alters Xlmo4 expres-
sion. Ventral misexpression of gsc mRNA (150 pg) down-
regulated Xlmo4 expression (84%, n  63; Fig. 2H). Taken
together these data suggest that Xlmo4 is activated in the
ventral mesoderm by BMP-4 signaling and downregulated
in the dorsal mesoderm by Organizer repressors, among
them, Gsc.
Xlmo4 can interfere with dorsal structures
We analyzed the function of Xlmo4 during development
by overexpressing it in different tissues. We used an MT-
Xlmo4 construct, which contains an Myc epitope fused
in-frame to Xlmo4. Injection of 2–4 ng of MT-Xlmo4
mRNA in the prospective ectoderm or in the ventral meso-
derm did not induce any visible alteration in tailbud em-
bryos (data not shown). However, a similar injection in the
dorsal mesoderm impaired formation of dorsal-anterior
structures (63%, n  72; Fig 3A and B). Similar results
were found with embryos injected with an inducible form of
Xlmo4 (MT-Xlmo4-IND, 0.5 ng). In the absence of Dex no
phenotype was observed (100%, n  42; Fig. 3C); but its
addition, before the start of gastrulation (stage 6), caused
strong suppression of dorsal-anterior structures (76%, n 
58; Fig. 3D). Phenotypes were progressively milder when
Dex addition was delayed to later stages (42–9%, n 
48–64; Fig. 5E and F, respectively). These data indicate
that Xlmo4 can interfere with dorsal mesoderm formation at
early gastrula stages. Similar results were obtained by over-
expressing 2–4 ng of a nontagged Xlmo4 mRNA (Fig. 3G).
Lmo proteins are known to sequester the cofactor Ldb1
from its complexes with different transcription factors, thus
interfering with the activity of these complexes (Mila´n and
Cohen, 1999; Mila´n et al., 1998; Shoresh et al., 1998; Thaler
et al., 2002; van Meyel et al., 1999; Weihe et al., 2001; Zeng
et al., 1998). Thus, we examined the effect of interfering
with Ldb1 by means of an Ldb dominant negative construct
(DN-Ldb; Bach et al., 1999). Injection of DN-Ldb mRNA (2
ng) in the dorsal mesoderm, similarly to the overexpression
of Xlmo4, strongly impaired the development of dorsal-
anterior structures (68%, n  44; Fig. 3H). Recently, it has
been shown that mice mutant for Ldb1 display defective
head structures, probably as a consequence of disrupting the
early Otx2 and Lim1 pathways (Mukhopadhyay et al.,
2003). In these mutant embryos, the expression of Wnt
antagonists is abrogated. Thus, it has been proposed that
suppression of head structures in Ldb1 mutant embryos is
the consequence of increased Wnt signaling due to the
impairment of early Otx2 and Lim1 pathways, which are
required for the expression of Wnt antagonists (Mukho-
padhyay et al., 2003). During Xenopus development, Otx2
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and Xlim1 are expressed and required for dorsal mesoderm
fomation. Thus, we have examined the effect of Xlmo4
overexpression in these and other dorsal mesoderm genes.
We observed similar effects in embryos injected with MT-
Xlmo4 mRNA (2–4 ng; not shown) or MT-Xlmo4-IND (0.5
ng) mRNA in the presence (Fig. 4), but not in the absence
(insets in Fig. 4), of the hormone Dex. Overexpression of
these forms of Xlmo4 mRNAs downregulated the dorsally
expressed transcription factors (gsc and Otx2) and the an-
tagonists of the Bmp4 (chordin, chd) and the Wnt [cerberus
(cer) and Frizzled-b (Frzb)] pathways (57–64%, n  36–
63; Fig 4A–E). These repressions were not associated with
the activation of ventral markers, such as Xvent1 and Xwnt8
(100%, n  35–48; Fig. 4F and G). In addition, these genes
were not affected by ventral overexpression of Xlmo4
mRNAs (not shown). Double staining of Xlim1 and Xlmo4
at early gastrula stages indicates that both genes are coex-
pressed before Xlmo4 is downregulated in the dorsal-most
mesoderm (Fig. 4H). Thus, before its expression is removed
from the dorsal mesoderm, Xlmo4 may be restricting the
availability of Ldb1 for organizer-expressed transcription
factors.
We have also examined whether the suppression of head
structures observed upon Xlmo4 overexpression is caused
by the downregulation of Wnt inhibitors, and thus it is an
indirect consequence of the increased activity of the Wnt
pathway in the dorsal mesoderm. To test this, we coex-
pressed in the dorsal mesoderm MT-Xlmo4-IND (0.5 ng)
mRNA and an mRNA encoding a dominant negative form
of Wnt8 (DN-Wnt8, 0.5 ng), which suppresses Wnt signal-
ing (Hoppler et al., 1996). The DN-Wnt8 restored the dorsal
anterior structures (Fig. 3I and J), indicating that the sup-
pression of these structures in Xlmo4-injected embryos is
probably due to the reduction of Wnt inhibitors and the
concomitant increased Wnt signaling.
Xlmo4 is required for ventral mesoderm identity
Xlmo4 expression in the ventral mesoderm suggests a
function of this gene in this territory. It is known that Lmo
proteins act as positive cofactors of several transcription
factors of the bHLH and GATA classes (Bao et al., 2000;
Mead et al., 2001; Osada et al., 1995; Sugihara et al., 1998;
Vitelli et al., 2000; Wadman et al., 1997) and that GATA
factors participate in formation of the ventral mesoderm
(Sykes et al., 1998). Hence, we first attempted to interfere
with Xlmo4 function by means of a morpholino antisense
oligonucleotide designed to bind to the Xlmo4 translation
start site. Although injection of 10 ng of this morpholino
effectively suppresses translation of 2 ng of an Xlmo4
construct bearing an Myc epitope at the carboxy-terminus
(Xlmo4-MT), we did not detect a phenotypic effect in em-
bryos injected with up to 50 ng of such morpholino (not
shown). Thus, it is possible that this morpholino is unable to
block translation of the endogenous gene, or alternatively,
that other Lmo proteins rescue the loss of function of
Xlmo4.
On the other hand, if Lmo4 acts as a positive cofactor of
some transcription factor(s), a chimeric fusion of Lmo4 with
the Engrailed repressor domain, which behaves as a domi-
nant negative in cell culture transcription assays (Andersen,
B., unpublished data), might interfere with this function.
Thus, we tested the effects of this chimera and compared
them with those of a dominant negative GATA construct
(Gata-En). Gata-En interferes with several GATA factors,
which are required for ventral mesoderm formation during
gastrulation (Sykes et al., 1998). Overexpression of
Lmo4-En mRNA (2 ng) in ventral mesoderm dorsalized the
injected embryos (48%, n  92; Fig. 5A). In contrast,
coinjection of Lmo4-En mRNA and MT-Xlmo4 mRNA es-
sentially abolished this effect (94%, n  100, Fig. 5B). This
indicated that Lmo4-En interferes specifically with the func-
tion of Xlmo4. The dorsalization caused by Lmo4-En was
similar, although weaker, to that produced by ventral over-
expression of Gata-En mRNA (0.2 ng; Fig. 5C). Interfer-
ence with Xlmo4 function ectopically activated the dorsal
gene gsc (75%, n  54), but not other dorsal markers such
as chordin (chd), cerberus, or XlimI (100%, n  46; Fig 5G,
and not shown). In addition, the ventral markers Xvent1
(75%, n  34; Fig. 5J) and Xwnt8 (50%, n  40; Fig. 5M),
but not Xvent2 (not shown), were repressed. Consistent with
the partial dorsalization observed, at early neurula stages,
the dorsal mesoderm genes MyoD and sonic hedgehog (shh)
were not expressed ectopically in the ventral side of these
injected embryos (not shown). Coexpression of Lmo4-En
and MT-Xlmo4 mRNAs rescued these effects (Figs. 5E, K
and N). Thus, ectopic gsc was observed in only 10% of the
coinjected embryos (Fig. 5E) and repression of Xvent1 and
Xwnt8 was detected in only 17% and 10% of the embryos (n
 36–40, Fig. 5K and N, respectively). Other Xenopus Lmo
genes were not tested in this rescue assay since they are not
expressed at gastrula stages in the ventral mesoderm. As
previously shown (Sykes et al., 1998), ventral interference
with GATA function is also accompanied by repression of
Xvent1 (63%, n  16; Fig. 5L) and Xwnt8 (60%, n  20;
Fig. 5O) but not of Xvent2 (not shown). However, in em-
Fig. 3. Xlmo4 prevents dorsal mesoderm formation. Lateral views of stage 35 embryos injected with the corresponding mRNAs. These mRNAs were
coinjected with lacZ mRNA (300 pg). (A) Control embryo injected only with lacZ mRNA. (B) Embryos injected with 4 ng of MT-Xlmo4 mRNA;
dorso-anterior structures are missing. (C) Embryos injected with 500 pg of MT-Xlmo4-IND mRNA; they are normal in the absence of the hormone. (D–F)
Embryos injected as in (C) and Dex added before gastrulation, at early gastrula or at late gastrula, respectively; the dorso-anterior structures are strongly, mid,
or not suppressed. (G and H) Embryos injected with nontagged Xlmo4 (4 ng, H) or DN-Ldb (2 ng, G) mRNAs showed similar suppression of dorso-anterior
structures. (I and J) Embryos coinjected with MT-Xlmo4-IND and DN-Wnt8 mRNAs (500 pg) show enlarged heads both in the absence (I) or in the presence
(J) of Dex.
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bryos injected with Gata-En mRNA, chd but not gsc was
ectopically activated (80–100%, n  20–18; Fig. 5I and F,
respectively). These effects were not rescued by coexpres-
sion of MT-Xlmo4 mRNA (not shown). This indicated that
interference with Xlmo4 and GATA function caused similar
although not identical effects.
As mentioned above, Lmo2 binds to and acts as a co-
factor of GATA1 during blood formation (Mead et al.,
2001; Osada et al., 1995; Vitelli et al., 2000; Wadman et al.,
1997). Therefore, it seemed possible that Lmo4 might also
bind to and act as a cofactor of GATA factors. In fact,
Gata2, 4, 5, and 6, but not Gata1, are expressed at and
required for ventral mesoderm formation during gastrula-
tion (Bertwistle et al., 1996; Kelley et al., 1994; Sykes et al.,
1998; Walmsley et al., 1994). By means of coimmunopre-
cipitation assays we have detected a physical interaction
between Lmo4 and GATA2 similar to that observed be-
tween Lmo4 and Ldb1 (Fig. 6A). Moreover, GST-pulldown
experiments have allowed us to confirm that this interaction
is direct and to determine that Lmo4 interacts with the
N-terminal region of GATA2 (amino acids 1–266), which
contains the activation domain, but not with the C-terminal
region (amino acids 257–452), which contains the zinc-
finger region (Fig. 6B). The same results were observed in
coimmunoprecipitation assays performed with transfected
cells (not shown). To further test whether GATA2 and
Xlmo4 act in the same pathway during ventral mesoderm
formation, we examined in coinjection experiments whether
they have synergistic ventralizing effects. Embryos injected
with suboptimal concentrations of Gata2 (100 pg) or MT-
Xlmo4 (500 pg) mRNAs developed with little or no sign of
ventralization (Fig. 6C and D; 100–96%, n  45–52, re-
spectively). However, embryos injected with both mRNAs
showed clear ventralization phenotypes (Fig. 6E, 34%, n 
53). We conclude that, similarly to Lmo2, Lmo4 is a posi-
tive cofactor of GATA’s during ventral mesoderm forma-
tion.
Xlmo4 participates in neural plate regionalization
Since we identified Xlmo4 as a gene positively regulated
by Xiro1, we examined its function during neural develop-
ment by overexpressing Xlmo4 mRNA. To prevent early
mesodermal effects during gastrulation, we injected MT-
Xlmo4-IND mRNA (0.5 ng) and added Dex at the end of
gastrulation (stage 12). In these embryos, we observed a
downregulation of the proneural gene Xngnr1 (67%, n 
43; Fig. 7A, arrow) and a reduction of the number of
primary neurons, as determined by N-tubulin expression
(58%, n  43; Fig. 7D; arrow). No effects were observed in
the absence of Dex (Fig. 7A and D, insets). Injection of
Lmo4-En mRNA also reduced expressions of XngnrI and
N-tubulin (80–60%, n  40–30; Fig. 7B and E, arrows,
respectively). These results suggest that overexpression of
either Xlmo4 or Lmo4-En similarly prevents primary neu-
ron differentiation. Thus, in this context, Lmo4-En does not
behave as a dominant negative molecule. It is possible that,
as it occurs in the dorsal mesoderm, Xlmo4 withholds Ldb1
from transcription factors that are necessary for neuronal
differentiation. This would be consistent with Lmo4-En not
acting as a dominant negative molecule, since, despite its
repression domain, this chimeric protein should still seques-
ter Ldb1. In support of this interpretation, we have observed
that, in the dorsal mesoderm, Lmo4-En does not interfere
with Xlmo4 function and behaves like this protein in pre-
venting dorsal mesoderm development (not shown). If
Xlmo4 or Lmo4-En do sequester Ldb1 in the neural plate, it
would be expected to find similar effects upon interference
with Ldb1 function. To test this, we examined the effect of
overexpressing a dominant negative form of Lbd protein
(DN-Ldb). DN-Ldb mRNA (1 ng) downregulated both
Xgnr1 and N-tubulin (60–62%, n  25–32; Fig. 7C and F,
arrows, respectively).
Impairment of Ldb1 function, both in mice mutant for
this gene or by overexpression of DN-Ldb mRNA in
zebrafish, disrupts gene expression at the Isthmus Orga-
nizer, which is located at the midbrain-hindbrain (M/H)
boundary (Becker et al., 2002; Mukhopadhyay et al.,
2003). Thus, we examined the effect of overexpressing
MT-Xlmo4-IND (0.5 ng) in this territory at the end of
gastrulation. Otx2 was either not affected or slightly
shifted posteriorly (50%, n  36; Fig. 7G, compare black
and red arrows in the injected and control sides, respec-
tively). In contrast both Gbx2 and En2 were downregu-
lated (78 –58%, n  54 –36; Fig. 7J and M, arrows,
respectively). These effects were not observed in the
absence of the hormone (Fig. 7G, J, and M; insets).
Similar effects were observed in embryos injected with
Lmo4-En mRNA (2 ng) (64 – 82%, n  33– 42; Fig. 7H,
K, and N, black arrows) or in embryos injected with
DN-Ldb mRNA (1 ng) (55–57%, n  33–35; Fig. 7I, L,
and O, black arrows). These data indicate that Xlmo4
regulates Ldb1 availability for transcription factors re-
quired for both primary neurogenesis and Isthmus Orga-
nizer formation.
Fig. 4. Xlmo4 overexpression downregulates gene expression at the dorsal mesoderm. (A–G) Vegetal views of early gastrula embryos injected with
MT-Xlmo4-IND mRNA (500 pg) treated with Dex at stage 6. In these embryos the dorsal genes gsc (A), otx2 (B), chd (C), cer (D), and Frzb (E) are repressed,
but the ventral gene Xvent1 (F) and Xwnt8 (G) are not ectopically activated in the dorsal side. Repression of dorsal gene expression was not observed in similar
injected embryos not treated with the hormone (A–E, insets). (H) Vegetal view of an early gastrula embryo showing the expression of Xlmo4 (cyan) and Xlim1
(purple). Note that both genes are coexpressed in the dorsal mesoderm. Inset shows the same embryo after the first chromogenic reaction to detect Xlmo4
mRNA (cyan).
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Discussion
Xlmo4 is a GATA cofactor required for ventral mesoderm
formation and a negative modulator of the activity of
Ldb1-dependent organizer genes
During gastrulation Xlmo4 is initially expressed both at
the dorsal and ventral mesoderm while later its expression is
downregulated in the dorsal-most mesoderm. The expres-
sion of Xlmo4 in the mesoderm seems to depend on positive
factors such as Bmp4 and negative regulators such as Gsc,
which may mediate dorsal downregulation of Xlmo4 as
gastrulation proceeds. In the ventral mesoderm, we find that
decreasing the function of Xlmo4 with an Lmo4-En chi-
meric protein, which in this context acts as a dominant
negative molecule, promotes partial dorsalization of the
embryos. This is evidenced by the repression of the ventral
mesoderm markers Xvent1 and Xwnt8 and the activation of
the dorsal gene gsc. Other dorsal markers assayed (chd,
cerberus, Xlim1, MyoD, and shh) are not ventrally activated.
This could explain the weak dorsalization observed in these
embryos. We do not know why the ectopic activation of gsc
does not promote a full dorsalization program by activating
other dorsal mesoderm genes. One possibility is that the
levels of ectopic gsc promoted by interference with Xlmo4
function are insufficient for the activation of other dorsal
mesoderm genes.
The LIM only protein Lmo2 has been shown to form a
multiprotein complex with Ldb1, GATA1, and the bHLH
factors SCL and E12/E47, which are required for develop-
ment of the blood tissue in Xenopus and the hematopoietic
system in other vertebrates (Mead et al., 2001; Osada et al.,
1995; Pevny et al., 1991; Vitelli et al., 2000; Wadman et al.,
1997). The blood derives from the most ventral mesoderm.
In Xenopus, Gata1 and Xlmo2 are expressed during late
neurula in territories in which blood will form (Kelley et al.,
1994; Mead et al., 2001). However, Gata1 is not expressed
in the ventral mesoderm at early gastrula stages. So its
interaction at this stage with Xlmo4 is most unlikely. In
contrast, Gata2, 4, 5, and 6 are all expressed during gastru-
lation in the ventral mesoderm and the function of these
genes is required for the correct development of this terri-
tory (Bertwistle et al., 1996; Kelley et al., 1994; Sykes et al.,
1998; Walmsley et al., 1994). Indeed, interference with their
function partially dorsalizes embryos and generates axis
duplications as a result of the downregulation of ventral
mesoderm genes and the ectopic ventral activation of some
dorsal genes (Sykes et al., 1998). Thus, it is possible that
during ventral mesoderm formation Xlmo4 acts as a posi-
tive cofactor of some of these GATA factors. We have
found, by means of GST-pulldown and coimmunoprecipi-
tation assays, that there is indeed an interaction between
Lmo4 and GATA2. We have mapped this interaction within
the N-terminal region of GATA2, in which the activation
domain is located. Moreover, we have found that coinjec-
tion of Gata2 and Xlmo4 act synergistingly to promote
ventral fates. These results strongly suggest that Xlmo4 is a
cofactor of GATA proteins during early ventral mesoderm
formation. Ldb1 may also participate in this complex. In-
deed, mice mutant for Ldb1 show a posterior axis duplica-
tion (Mukhopadhyay et al., 2003), and we have observed a
partial dorsalization of embryos ventrally injected with a
dominant negative Ldb1 construct (not shown). Thus, it is
likely that, similar to the multiprotein complex required for
blood formation, a related complex formed by Xlmo4,
GATA factors, and probably Ldb1 is required for ventral
mesoderm formation. Other Xenopus Lmo proteins may
also interact with GATA factors during ventral mesoderm
formation. However, neither Xlmo2 nor Xlmo3 are ex-
pressed in this territory during gastrulation (Bao et al., 2000;
Mead et al., 2001). This indicates that Xlmo4 is the main
candidate to act as cofactor for GATA molecules present in
the ventral mesoderm during gastrulation. However, over-
expression of Xlmo4 cannot rescue the dorsalization caused
by interference of GATA function by Gata-En mRNA. It is
likely that the GATA-En chimeric protein interferes with
GATA activity by binding to GATA sites in the regulatory
region of downstream genes. The chimeric protein would
then repress these downstream genes. This repression would
not be affected by overexpression of Xlmo4 since
GATA-En does not contain the Xlmo4 binding domain.
Interestingly, interference with Xlmo4 function in the ven-
tral mesoderm promotes the ectopic expression of gsc, but
not that of other dorsal genes, while that with GATA factors
causes ventral ectopic expression of chd but not of gsc.
Thus, it is possible that, in the ventral mesoderm, Xlmo4
acts also as a cofactor for other ventral transcription factor
distinct from those of the GATA family.
As mentioned above, at the beginning of gastrulation
Xlmo4 is present all around the mesoderm and thus it is
coexpressed with organizer genes. However, dorsal Xlmo4
expression soon disappears, probably by repression medi-
ated by some organizer transcription factors such as Gsc.
This downregulation seems to be important for the proper
development of the dorsal mesoderm, since overexpression
of Xlmo4 in the dorsal mesoderm represses many organizer
genes. Lmo proteins are known to interfere with LIM ho-
meoproteins, and possible other transcription factors, by
binding and sequestering the cofactor Ldb1 from it com-
plexes with those factors (Mila´n and Cohen, 1999; Mila´n et
al., 1998; Shoresh et al., 1998; Thaler et al., 2002; van
Meyel et al., 1999; Weihe et al., 2001; Zeng et al., 1998).
One possibility is that Xlmo4 may regulate Ldb1 availabil-
ity for dorsally expressed transcription factors. Two candi-
dates are Xlim1 and Otx2, both of which are required for
dorsal mesoderm formation (reviewed in Bach, 2000; Da-
wid et al., 1998; Hobert and Westphal, 2000). Indeed, over-
expression of Xlmo4 in the dorsal mesoderm cause similar
effects that those observed in mice mutant for Ldb1 (our
data and Mukhopadhyay et al., 2003). In these embryos Wnt
inhibitors are downregulated, and probably as a conse-
quence of increased Wnt signaling, dorso-anterior structures
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Fig. 5. Xlmo4 participates in ventral mesoderm identity. Lateral views of stage 35 (A and C) or vegetal views of stage 10.5 (D–O) embryos injected with
the indicated mRNAs together with lacZ mRNA (300 pg). The injection side was determined by X-Gal staining. (A, D, G, J, and M) Embryos injected with
2 ng of Lmo4-En mRNA are dorsalized (A) probably as a result of the ectopic ventral expression of gsc (D, arrowhead) and the repression of Xvent1 (J,
arrowhead) and Xwnt8 (M, arrowhead) genes. The dorsal gene chd was not activated in the ventral region of these injected embryos (G). (B, E, H, K, and
N) Coinjection of 2 ng of MT-Xlmo4 suppressed the effects observed in Lmo4-En injected embryos. (C, F, I, L, and O) Ventral overexpression of 200 pg
of Gata-En mRNA causes dorsalization of the embryos (C). In these embryos, the dorsal gene chd is ectopically activated in the ventral mesoderm (I,
arrowhead), while the ventral markers Xvent1 (L, arrowhead) and Xwnt8 (O, arrowhead) are suppressed. Note that gsc is not activated in the ventral mesoderm
of these injected embryos (F).
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are impaired (our data and Mukhopadhyay et al., 2003).
Similarly, we find that suppression of head structures upon
Xlmo4 overexpression is rescued by interfering with Wnt
signaling. Thus, before its expression is downregulated
from the dorsal mesoderm, Xlmo4 may negatively modulate
the activity of Xlim1 and Otx2 homeoproteins. In addition,
Xlmo4, which is later restricted to the ventral mesoderm,
may also restrict Ldb1 availability for some dorsal homeo-
proteins.
In summary, at early gastrula stages, it seems that Xlmo4
binds Ldb1 in all the marginal zone. However, while in the
ventral mesoderm Xlmo4 acts in concert with Ldb1 and
GATA to promote ventral identity, in the dorsal mesoderm the
Xlmo4-Ldb1 interaction sequesters Ldb1 and, consequently, it
negatively regulates the complexes formed with this cofactor
and some organizer homeoproteins. We conclude that at the
same developmental time Xlmo4 positively and negatively
regulates ventral and dorsal mesoderm formation, respectively.
Fig. 6. Lmo4 and GATA2 physically interact and synergize in promoting ventralization. (A) The indicated in vitro translated 35S-labeled GATA2 and Ldb1
proteins were coimmunoprecipitated with MT-Lmo4, using anti-Myc antibody or IgG. In a mixture of MT-Lmo4 and Ldb1 (lane 4) and MT-Lmo4 and
GATA2 (lane 6), anti-Myc antibody precipitated Ldb1 and GATA2, respectively, indicating that LMO4 interacts with Ldb1 and GATA2. IgG does not
precipitate these proteins, indicating that the effect is specific. The first three lanes show 10% of the proteins used for the immunoprecipitations. (B)
GST-pulldown assays to determine Lmo4 interaction with GATA2. The indicated in vitro translated 35S-labeled proteins were incubated either with GST
protein beads alone or GST-Lmo4 protein beads. A negative control radiolabeled Luciferase is not pulled down by GST-Lmo4 (lane 2). In contrast,
radiolabeled GATA2 is specifically precipitated by GST-Lmo4 (lane 5). A fragment of GATA2 containing the N-terminal region (aa: 1–266) but not the
C-terminal domain (aa: 257–452) interacts with GST-Lmo4, mapping the interaction domain to the N-terminus of GATA2. (C–E) Lateral views of stage 35
embryos injected with with lacZ mRNA (300 pg) and the indicated mRNAs. Embryos injected with either Gata2 or MT-Xlmo4 mRNAs (100 or 500 pg,
respectively) showed no sign of ventralization. In contrast, coinjection of both mRNAs promoted a clear ventralization phenotype.
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Fig. 7. Xlmo4 participate in neural development. All panels show dorsal views of neurula embryos injected with the indicated mRNAs together with lacZ
mRNA (300 pg). The injection side was determined by X-Gal staining. (A, D, G, J, and M) Embryos injected with 500 pg of MT-Xlmo4-IND mRNA and
treated with Dex at stage 12. In these embryos Xngnr1 (A), N-tubulin (D), Gbx2 (J), and En2 (M) are downregulated (arrows). In some of these embryos,
the expression domains of Otx2 and Krox20 are slightly shifted toward posterior (G, compare black and red arrows in injected and control sides). Insets in
these panels show similarly injected embryos not treated with Dex. Similar results were observed in embryos injected with 2 ng of Lmo4-En (B, E, H, K,
and N; arrows) or 1 ng of DN-Ldb (C, F, I, L, and O; arrows) mRNAs.
Xlmo4 is a Xiro-regulated gene that modulates Ldb1
activity in the neural plate
We have identified Xlmo4 in a screen designed to iden-
tify genes activated by Xiro. Consistently, we have found
that, during neurulation, Xiro and Xlmo4 are expressed in
coincidental domains symmetrically located at each side of
the midline, that these domains comprise part of the neuro-
genic ectoderm, and that their anterior limits extend up to
that of En2 within the Otx2 territory. These neural domains
appear after the onset of Xiro expression (Go´mez-Skarmeta
et al., 1998). Moreover, since an increase or a reduction of
Xiro function respectively activates or downregulates
Xlmo4, it is clear that the expression of Xlmo4 in the neural
plate is downstream of Xiro. However, Xiro does not di-
rectly activate Xlmo4, since the Xiro proteins participate in
this process as repressors. This seems to be also the case for
many other Xiro-dependent processes (de la Calle-Mus-
tienes et al., 2002a,b; Glavic et al., 2002; Go´mez-Skarmeta
et al., 2001).
Our data suggest that, in the neural plate, Xlmo4 nega-
tively modulates the availability of Lbd1 for transcription
factors that participate in primary neurogenesis and mid-
brain/hindbrain (M/H) boundary formation, probably by
sequestering this cofactor from active complexes. LIM ho-
meoproteins are known to participate in neuron differenti-
ation (reviewed in Bach, 2000; Dawid et al., 1998; Hobert
and Westphal, 2000). Thus, it is possible that Xlmo4 inter-
feres with the complexes formed by Ldb1 and LIM homeo-
proteins. However, although Xlim1 and 3 are respectively
expressed in the intermediate and medial stripes of primary
neurons, their expression occurs at relatively late stages,
when these neurons have already been singularized (Taira et
al., 1992,1993). Thus, these homeoproteins are probably
implicated in the acquisition of neuronal fate but not in the
initial differentiation of these neurons. This suggests that
Xlmo4 may negatively regulate primary neuron differenti-
ation through a different mechanism. In Drosophila, the
GATA factor Pannier (Pnr) is required for the activation of
proneural genes (Garcia-Garcia et al., 1999). The Ldb1
protein Chip interacts with Pnr and proneural proteins, and
this multiprotein complex seems to be required for neuronal
differentiation (Ramain et al., 2000). Moreover, overexpres-
sion of Drosophila Lmo removes Pannier-dependent sen-
sory organs (Ramain et al., 2000). It is thus possible that a
similar complex may be required for proneural gene expres-
sion and primary neurogenesis in Xenopus. Xlmo4 might
negatively modulate such a complex by sequestering Ldb1.
On the other hand, in Xenopus, Xlmo3 binds to and acts as
a positive cofactor of bHLH proneural proteins (Bao et al.,
2000). Thus, an additional possibility, that is not incompat-
ible with the previous one, is that Xlmo4 may compete with
Xlmo3 and generate inactive complexes with proneural pro-
teins. Consistently, we find that Xlmo4 expression coincides
with that of Xiro1 and neurons arise at the border of Xiro1
domains (de la Calle-Mustienes et al., 2002a). Thus, al-
though Xlmo4 expression overlaps with that of the proneural
gene Xngnr1, neurons arise within Xngnr1 domains devoid
of Xlmo4. The exact mechanism by which Xlmo4 prevents
primary neurogenesis will require identification of other
proteins that may interact with this cofactor.
It is of interest to note that Xiro proteins seem to help
define the territories in which neurons differentiate by
means of several parallel mechanisms. First, Xiro proteins
prevent primary neuron differentiation by indirectly activat-
ing the neuronal repressor XZic2 and XHairy2A (de la Calle-
Mustienes et al., 2002a). Second, Xiro proteins repress
XGadd45-, which seems to facilitate differentiating neu-
rons to exit from the cell cycle (de la Calle-Mustienes et al.,
2002a). And third, by activating Xlmo4 Xiro interferes with
transcription factors required for primary neurogenesis in
the neural plate.
We have also found that Xlmo4 participates in the spec-
ification of the M/H organizer. Thus, Xlmo4 is expressed in
this territory and its increased activity downregulates Gbx2
and En2. Otx2 is shifted caudally, probably as a conse-
quence of the Gbx2 repression. These effects are likely due
to the displacement of Ldb1 from active complexes formed
by this cofactor and different transcription factors. Candi-
dates are several LIM homeoproteins that are expressed in
this territory (Bach et al., 1997). Consistently with our
results, mice mutant for Ldb1 (Mukhopadhyay et al., 2003)
and zebrafish or Xenopus embryos in which Ldb1 function
is impaired by a dominant negative form of Ldb1 (Becker et
al., 2002), and our results) display a downregulation of M/H
genes.
Interestingly, Xiro1 is also required for the correct spec-
ification of the M/H organizer (Glavic et al., 2002). At least
part of this requirement may be effected by its downstream
gene Xlmo4.
If, as suggested, the overexpression of Xlmo4 in many
cases reduces the availability of Ldb1 for other transcription
factors, we would expect that increasing the levels of Ldb1
would rescue the effects associated with Xlmo4 overexpres-
sion. However, we have been unable to observe such rescue
(not shown). Moreover, embryos coinjected with Ldb1 and
Xlmo4 displayed phenotypes stronger that embryos injected
with Xlmo4 alone. It has been found in Drosophila that the
stoichiometry of the Lhx protein Ap and the Ldb1 homo-
logue Chip, which together form complexes containing two
Ap and two Chip proteins, is critical for the formation of the
dorsal compartment in the wing disc (Mila´n and Cohen,
1999; Rinco´n-Limas et al., 2000; van Meyel et al., 1999;
Weihe et al., 2001). Thus, Chip overexpression causes sim-
ilar defects to Chip loss of function, probably by the ability
of Chip to form multimeres that alter that precise stoichi-
ometry (Ferna´ndez-Fu´nes et al., 1998). A similar critical
stoichiometry may occur in Xenopus for those complexes
formed by Ldb1 and different homeoproteins. Xlmo4, by
binding to Ldb1, would probably regulate this stoichiometry
in vivo and, consequently, overexpression of Xlmo4 and/or
Ldb1 may alter it in a way incompatible with wild-type
578 E. de la Calle-Mustienes et al. / Developmental Biology 264 (2003) 564–581
function. It has been recently shown in Xenopus that the
RING finger protein Rnf12/RLIM is required in the Orga-
nizer to degrade the excess of Ldb1 that is not bound to
Xlim1. This degradation is important for dorsal mesoderm
formation since extra Ldb1 can alter the proper stoichiom-
etry of Xlim1/Lbd1 complexes. Indeed, overexpression of
Ldb1 downregulates Xlim1 target genes (Hiratani et al.,
2003). Thus, to rescue the effects of Xlmo4 overexpression
by increasing the levels of Ldb1 it would be necessary to
restore the exact stoichiometry of these complexes, a feat
difficult to achieve with mRNA injections. Rnf12/RLIM is
expressed at similar levels at the dorsal and the ventral
mesoderm. Thus, since at the dorsal mesoderm Xlim1 pre-
vents Rnf12/RLIM-mediated Ldb1 degradation, Ldb1
should be at lower levels in the ventral than in the dorsal
region. However, this is not the case and similar levels of
Ldb1 protein are found in all mesodermal territory. Hence,
it is possible that Xlmo4 binding to Ldb1 in the ventral
mesoderm prevents within this region its degradation by
Rnf12/RLIM (Hiratani et al., 2003). In contrast to the com-
plexes of dorsal mesoderm transcription factors and Ldb1,
which require a precise stoichiometry, those formed in the
ventral mesoderm by GATA, Ldb1, and Xlmo4 seem not to
be affected by overexpression of Xlmo4, as judged by
phenotypic effects and the expression of molecular markers.
This might result from an incapacity of Xlmo4 to multim-
erize and form alternative inactive complexes with Ldb1
and GATA.
In summary, Xlmo4 appears to participate in several
processes during development, both by acting as a positive
cofactor of transcription factors, such as those of the GATA
family, or by regulating the precise stoichiometry of com-
plexes formed by Ldb1 with other transcription factors.
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